Followers | 0 |
Posts | 105 |
Boards Moderated | 0 |
Alias Born | 07/15/2006 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 23, 2006 8:45:12 AM
In reply to: mainehiker who wrote msg# 705 Date:8/22/2006 10:32:50 PM
Post #of 712
"...it would be nice if people her[e] could be critical."
![wink](/images/emoticon03.gif)
It will speed up the process?
You're a glass half empty kinda guy, so the rest of us should be also?
Bashing the company you own helps exactly how?
You're planning a shareholder revolt of some sort?
It gives you the opportunity to 'vent your spleen'?
Perhaps some football games while you're waiting would refocus your energy and ease your frustration.
163L IS in trials, new sites keep cropping up every month or so.
Talk to the FDA about GRNVAC1 required IND paperwork, peer review, etc. and see if you can limit some of the delay. Take a look at the "tweaking" and see if it doesn't perhaps make some sense in retrospect to have investigated down those paths. While you're chatting with the FDA, you could see what the hold up in on the cloned meat and milk approval; you don't suppose that has anything to do with the Pres and the RR, do you?
Geron is certainly transitioning from R&D to products - and that's all I've heard him say. There are some minor products now, Roche due to sell the bladder cancer diagnostic in Europe later this year.
Certainly looks like Geron Bio-Med is ramping up and expanding. University of Edinburgh collaboration on three cell types. Work progressing on all the cell lines. Progress towards the spinal cord IND, religious right notwithstanding. Diabetes work in Canada. Feeder free patent. Two lines qualified for use, one of which is a "Bush approved line."
P&G license; Merck agreement; stART; TAT; new HIV/AIDS work; Invitrogen deal; two agreements with the University of Oxford relating to its program to produce dendritic cells from human embryonic stem cells (hESCs); MaxCyte and Cambrex agreements.
This is an exciting time and there are lots of developments; can you discuss any of them? Aureas suggested reviewing deal making, didn't see you respond to that.
*********************
great post, esammee. in the above you seem to put music to chrisclub's "geron's programs." mainehiker says he is long geron????? really????
Recent GERN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2024 07:44:18 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/20/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 09:53:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 04:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:03:44 PM
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia • Business Wire • 06/07/2024 01:58:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:05:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 09:02:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:05:30 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/16/2024 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2024 08:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:05:15 PM
- Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights • Business Wire • 05/02/2024 11:00:00 AM
- Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 • Business Wire • 04/25/2024 08:30:00 PM
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/18/2024 08:30:00 PM
- Geron to Participate at Upcoming Investor Conferences in April • Business Wire • 04/03/2024 08:30:00 PM
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM